Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heme Arginate in Cardiac Surgery
NCT02142699Phase 2Completed
- Sponsor
- University of Edinburgh
- Start
- Oct 2014
- Primary completion
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of heme arginate in acute kidney injury (AKI) (2 arms), sponsored by University of Edinburgh. Primary endpoint: Upregulation of Heme oxygenase-1 protein expression in circulating monocytes at 24 hours. Started Oct 2014; status: completed.
02
Drugs
heme arginate
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02142699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02142699.